Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Wockhardt Surges Over 10% on Strong Q2 Profit Turnaround

Healthcare/Biotech

|

Updated on 03 Nov 2025, 09:49 am

Whalesbook Logo

Reviewed By

Aditi Singh | Whalesbook News Team

Short Description :

Wockhardt Ltd. reported a net profit of ₹78 crore for the September quarter, a significant turnaround from a ₹22 crore net loss in the same period last year. Despite a 3.3% dip in revenue to ₹782 crore, the company's operating performance improved dramatically, with EBITDA rising 62% year-on-year to ₹178 crore and margins expanding substantially. The stock price reacted positively, surging over 10% after the results.
Wockhardt Surges Over 10% on Strong Q2 Profit Turnaround

▶

Stocks Mentioned :

Wockhardt Limited

Detailed Coverage :

Wockhardt Limited announced its financial results for the September quarter, which led to a substantial increase in its share price, with shares jumping up to 12% on Monday.

The company reported a net profit of ₹78 crore for the quarter, a strong recovery from the net loss of ₹22 crore it had posted during the corresponding quarter of the previous year.

Revenue for the period saw a slight decline of 3.3% year-on-year, totaling ₹782 crore. However, the company's operational efficiency and profitability showed significant improvement.

Earnings Before Interest, Tax, Depreciation, and Amortisation (EBITDA) grew robustly by 62% compared to the previous year, reaching ₹178 crore. This was accompanied by a considerable expansion in operating margins, which widened from 13.6% to 22.8%, an increase of over 900 basis points.

Following the announcement of these results, Wockhardt shares traded approximately 10.4% higher at ₹1,415. Year-to-date, the stock has seen a marginal decrease of 2.5%.

Impact: This news indicates a positive shift in Wockhardt's financial health, driven by improved operational management and profitability. The strong turnaround in profit and margin expansion are key positive signals for investors, leading to a favorable short-term stock performance. Impact Rating: 7/10

Definitions: EBITDA (Earnings Before Interest, Tax, Depreciation, and Amortisation): A measure of a company's operating performance before accounting for interest, taxes, depreciation, and amortization expenses. It is used to assess the profitability of a company's core business operations. Basis Points: A unit of measure equal to 1/100th of a percent (0.01%). For example, an increase of 900 basis points in margin means the margin increased by 9 percentage points.

More from Healthcare/Biotech


Latest News

Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.

Auto

Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.

Stocks to buy: Raja Venkatraman's top picks for 4 November

Brokerage Reports

Stocks to buy: Raja Venkatraman's top picks for 4 November

Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth

Mutual Funds

Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth

Why Pine Labs’ head believes Ebitda is a better measure of the company’s value

Tech

Why Pine Labs’ head believes Ebitda is a better measure of the company’s value

SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?

Banking/Finance

SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?

India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)

Industrial Goods/Services

India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)


Renewables Sector

Brookfield lines up $12 bn for green energy in Andhra as it eyes $100 bn India expansion by 2030

Renewables

Brookfield lines up $12 bn for green energy in Andhra as it eyes $100 bn India expansion by 2030


Energy Sector

India's green power pipeline had become clogged. A mega clean-up is on cards.

Energy

India's green power pipeline had become clogged. A mega clean-up is on cards.

More from Healthcare/Biotech


Latest News

Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.

Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.

Stocks to buy: Raja Venkatraman's top picks for 4 November

Stocks to buy: Raja Venkatraman's top picks for 4 November

Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth

Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth

Why Pine Labs’ head believes Ebitda is a better measure of the company’s value

Why Pine Labs’ head believes Ebitda is a better measure of the company’s value

SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?

SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?

India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)

India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)


Renewables Sector

Brookfield lines up $12 bn for green energy in Andhra as it eyes $100 bn India expansion by 2030

Brookfield lines up $12 bn for green energy in Andhra as it eyes $100 bn India expansion by 2030


Energy Sector

India's green power pipeline had become clogged. A mega clean-up is on cards.

India's green power pipeline had become clogged. A mega clean-up is on cards.